Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 11-12, 2003, Pages 882-883

  Lin, Jen Tsun ^a   Wang, Wei Shu ^a   Yen, Chueh Chuan ^a   Liu, Jin Hwang ^a   Chiou, Tzeon Jye ^a   Yang, Mu Hua ^a   Chao, Ta Chon ^a   Chen, Po Min ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; ERYTHROMYCIN; FLUCONAZOLE; FLUDARABINE; IMIPENEM; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; TETRACYCLINE; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BLOOD CULTURE; CASE REPORT; CHRONIC GRAFT REJECTION; CHRYSEOBACTERIUM INDOLOGENES; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS CATHETER; LEUKEMIA; MALE; OUTCOMES RESEARCH; RECIPIENT;

ADULT; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTEREMIA; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CHRYSEOBACTERIUM; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FLAVOBACTERIACEAE INFECTIONS; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID, CHRONIC; MALE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0346968470     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310016637     Document Type: Article

References (8)

1. Hsueh PR, Hsiue TR, Wu JJ, Teng LJ, Ho SW, Hsieh WC, et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996; 23: 550-5.
2. von Graevenitz A. Acinetobacter, A caligenes, Moraxella, and other non-fermentative Gram-negative bacteria. In: Murray PR, ed. Manual of Clinical Microbiology Washington DC: ASM Press; 1995. p. 520-32.
3. Hsueh PR, Teng LJ, Ho SW, Hsieh WC, Luh KT. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with internal mechanical devices. J Clin Micro 1996; 34: 1908-13.
4. Chang JC, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT. Antimicrobial susceptibility of Flavobacteria as determined by agar dilution and disc diffusion methods. Antimicrob Agents Chemother 1997; 41: 130-1.
5. Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997; 16: 568-74.
6. Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001; 17: 391-3.
7. Lu PC, Chan JC. Flavobacterium indologenes keratitis. Ophthalmologica 1997; 211: 98-100.
8. Green BT, Nolan PE. Cellulitis and bacteremia due to Chryseobacterium indologenes. J Infect 2001; 42: 219-20.